Research Papers:

Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer

Tu Dao, Guillaume Gapihan, Christophe Leboeuf, Diaddin Hamdan, Jean-Paul Feugeas, Hanene Boudabous, Laurent Zelek, Catherine Miquel, Thuan Tran, Catherine Monnot, St├ęphane Germain, Anne Janin _ and Guilhem Bousquet _

PDF  |  Full Text  |  Supplementary Files  |  How to cite  |  Press Release

Oncotarget. 2020; 11:1590-1602. https://doi.org/10.18632/oncotarget.27553

Metrics: PDF 1394 views  |   Full Text 2124 views  |   ?  


Tu Dao1,2,3,9,*, Guillaume Gapihan1,*, Christophe Leboeuf1, Diaddin Hamdan1, Jean-Paul Feugeas4,10, Hanene Boudabous5, Laurent Zelek5,6, Catherine Miquel1,7, Thuan Tran2,3, Catherine Monnot8, Stéphane Germain8, Anne Janin1,7,# and Guilhem Bousquet1,5,6,#

1 Université Paris Diderot, Inserm, UMR_S942, Paris, France

2 Medical Oncology Department, National Cancer Hospital, Ha Noi, Vietnam

3 Ha Noi Medical University, Oncology Department, Ha Noi, Vietnam

4 INSERM, U722-Paris, Paris, France

5 Oncology Department, Hôpital Avicenne, APHP, Bobigny, France

6 Université Paris 13, Villetaneuse, Paris, France

7 Pathology Department, Hôpital St Louis, APHP, Paris, France

8 Center for Interdisciplinary Research in Biology (CIRB), College de France, CNRS, INSERM, PSL Research University, Paris, France

9 Cancer Research and Clinical Trial Center, National Cancer Hospital, Ha Noi, Vietnam

10 Université de Franche Comté, Besançon, France

* These authors contributed equally to this work

# These authors are co-senior authors

Correspondence to:

Guilhem Bousquet,email: [email protected]
Anne Janin,email: [email protected]

Keywords: cANGPTL4; brain metastases; breast cancer; blood-brain barrier; vascular permeability

Received: November 27, 2019     Accepted: March 19, 2020     Published: May 05, 2020


Background: Brain metastases challenge daily clinical practice, and the mechanisms by which cancer cells cross the blood-brain barrier remain largely undeciphered. Angiopoietin-like 4 (ANGPTL4) proteolytic fragments have controversial biological effects on endothelium permeability. Here, we studied the link between ANGPTL4 and the risk of brain metastasis in cancer patients.

Materials and Methods: From June 2015 to June 2016, serum samples from 113 cancer patients were prospectively collected, and ANGPTL4 concentrations were assessed. Using a murine model of brain metastases, we investigated the roles of nANGPTL4 and cANGPTL4, the two cleaved fragments of ANGPTL4, in the occurrence of brain metastases.

Results: An ANGPTL4 serum concentration over 0.1 ng/mL was associated with decreased overall-survival. Multivariate analyses found that only breast cancer brain metastases were significantly associated with elevated ANGPTL4 serum concentrations.

4T1 murine breast cancer cells were transfected with either nANGPTL4- or cANGPTL4-encoding cDNAs. Compared to mice injected with wild-type 4T1 cells, mice injected with nANGPTL4 cells had shorter median survival (p < 0.05), while mice injected with cANGPTL4 had longer survival (p < 0.01). On tissue sections, compared to wild-type mice, mice injected with nANGPTL4 cells had significantly larger surface areas of lung metastases (p < 0.01), and mice injected with cANGPTL4 had significantly larger surface areas of brain metastases (p < 0.01).

Conclusions: In this study, we showed that a higher expression of Angiopoietin-like 4 Fibrinogen-Like Domain (cANGPTL4) was associated with an increased risk of brain metastases in women with breast cancer.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27553